Build Your Company with Strategic AlliancesMarch 15, 2022 | 7:00 pm - 8:30 pm ET | Free Webinar
A Ginkgo Perspective to Build Your Company with Strategic Alliances
David Borhani, Director, Platform Commercialization, Pharma Ginkgo Bioworks, Inc.
Growth Through Partnerships – Lessons Learned
Sridhar Iyengar, CEO & Founder, Elemental Machines
LabCentral – Build Your Company with Strategic Alliances
Rachele Ryan, Director of Partnerships, LabCentral
Build Your Company with Strategic Alliances: Pros & Cons
Anh Hoang, Founder of Sofregen Medical
Being a successful entrepreneur often takes a special kind of person. An inventor, innovator, willing to work hard, long hours to build an idea, a dream, into a company. It would be a mistake, though, to assume that entrepreneurship means a solo slog through a long, lonely path to success. Building and growing a company generally requires considerable expertise and resources that go well beyond invention. Assuming proper steps have been taken to secure Freedom to Operate, identify a suitable gap in the competitive landscape, plot out a business strategy, and generate specifications for the product candidate/prototype, the work is not done. Depending on the complexity of the specific asset, product development can be a years-long process, requiring specialized expertise, including process manufacturability and scaling, quality control, raw materials sourcing and supply chain logistics, applicable regulatory compliance, distribution, pricing, marketing, sales, and the list goes on.
While a truly gifted entrepreneur certainly can build a successful company organically, hiring the right expertise at the right time, and essentially going it alone, Strategic Alliances can be leveraged to speed the process, and can even be an integral part of the product monetization strategy. Whether the goal is speed to market by securing specialized expertise and resources, tapping established regulatory infrastructure and distribution channels, or paving a path to a lucrative financial exit, well considered collaborations can nicely complement a brilliant entrepreneur’s innovative thinking.
Tonight’s panelists will share their stories about their respective organization’s approaches to catalyzing success with strategic alliances.
Event ScheduleMarch 15, 2022
Rachele RyanDirector of Partnerships, LabCentral
Rachele Ryan is the Director of Partnerships at LabCentral, a Massachusetts non-profit organization, founded in 2013 as a launchpad for high-potential life sciences and biotech startups. In this role she is responsible for business development strategy, resident company growth and development, and leading entrepreneurship programming for LabCentral’s newest initiative, LabCentral Ignite.
Rachele’s professional career has revolved around connecting startups to the Boston/Cambridge innovation ecosystem. Prior to joining LabCentral, Rachele led the MassCONNECT mentoring program at MassBio, the Massachusetts biopharma industry association. In that role, she matched life sciences entrepreneurs and founders with seasoned life science professionals to catalyze and commercialize innovation. Previously, as a part of the International Business Development team at the Consulate General of Canada in Boston, she assisted Canadian companies with their expansion efforts into New England and supported fast-growing startups participating in the Canadian Technology Accelerator in Boston (CTA@Boston).
Rachele holds a BA from College of the Holy Cross and an MA from Middlebury College. She currently serves as an Advisory Board member for the digital-health focused accelerator PharmStars.
Anh HoangFounder of Sofregen Medical
Anh Hoang is the founder of Sofregen Medical, a company that is re-inventing ancient silk technologies for medical treatments. At Sofregen, Anh operates as the chief science officer and serves on the board of directors. Under her leadership, Sofregen received the first FDA cleared product made from reconstituted silk protein for the treatment of vocal fold insufficiency.
Outside of Sofregen, Anh is a faculty at the Massachusetts Institute of Technology’s (MIT) Catalyst LinQ program and serves on the Steering Committee of MassMedic Ignite Program. She was a recipient of the 2018 Medtech Boston 40 under 40 Healthcare Innovators. Anh completed her doctorate degree (Ph.D) in material science engineering from Vanderbilt University and her postdoctoral fellowship at Harvard Medical School and Mass General Hospital as an Executive Committee on Research fellow. Anh is a proud graduate of Mount Holyoke College where she earned her bachelor’s degree in biochemistry.
Aaron SchwartzSenior Director, Pharma and Biotech Business Development, Ginkgo Bioworks
Aaron has been Senior Director in the Pharma and Biotech Business Development team at Ginkgo Bioworks since 2021. In this role, Aaron is responsible for establishing new partnerships with Pharma and Biotech from early discovery through process optimization/scale-up. Before joining Ginkgo, Aaron was a Director in Novo Nordisk’s Search & Evaluation team for Global Drug Discovery from 2016. During this time, Aaron was responsible for the search and evaluation of new therapeutics and enabling technologies for protein, peptide, and antibody drugs. He helped Novo Nordisk access over 70 different external opportunities during this time. Prior to joining Novo Nordisk, Aaron worked in the MIT Technology Licensing Office for 13.5 years. During this time, he worked on license and sponsored research agreements with life sciences companies from startups to big biotech/pharma and everything in between. He also managed a portfolio of over 650 technologies. Before Aaron’s time at MIT, he was a management consultant to big pharma and a startup. Aaron has an undergrad degree in biology from the University of Chicago and a Masters degree in biology from MIT.
Sridhar IyengarCEO & Founder, Elemental Machines
A serial entrepreneur in IoT, medical devices and wearables, Sridhar was a founder of Misfit, makers of elegant wearable products acquired by Fossil in 2015. Prior to Misfit, he founded AgaMatrix based on his PhD research, a blood glucose monitoring company that made the world’s first iPhone-connected medical device. Sridhar holds more than 50 U.S. and international patents and received his Ph.D. from Cambridge University as a Marshall Scholar.
Moderator & Organizers
Roger FrechettePrincipal and Founder, NEPAssociates, LLC
Roger is a life sciences consultant/advisor, helping clients by leveraging an extensive global network and multi-disciplinary insights derived from >20 years of experience in the business of life sciences, calibrated with an extensive science background. His career has encompassed success as a business executive, project/alliance manager and entrepreneur, and as a scientist, including leadership of discovery/preclinical development teams resulting in two FDA approved therapeutics. Roger has been a volunteer with Boston ENET since 2014, in addition to supporting start-ups as a mentor with MassBio, and other Greater Boston Area entrepreneur support groups. He also a mentor with 12Ronnies, a global early-stage startup mentorship organization.